GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
25.64
-1.30 (-4.81%)
Mar 31, 2025, 1:15 PM EDT - Market open
GRAIL Revenue
In the year 2024, GRAIL had annual revenue of $125.60M with 34.90% growth. GRAIL had revenue of $38.25M in the quarter ending December 31, 2024, with 26.14% growth.
Revenue (ttm)
$125.60M
Revenue Growth
+34.90%
P/S Ratio
6.84
Revenue / Employee
$125,595
Employees
1,000
Market Cap
868.90M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
GRAL News
- 4 weeks ago - GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 4 weeks ago - GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing - PRNewsWire
- 5 weeks ago - GRAIL to Present at TD Cowen 45th Annual Health Care Conference - PRNewsWire
- 5 weeks ago - GRAIL, Inc. (GRAL) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire
- 6 weeks ago - GRAIL to Announce Fourth Quarter 2024 Financial Results - PRNewsWire
- 6 weeks ago - GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System - PRNewsWire
- 2 months ago - Watch These Grail Price Levels After Med Tech Company's Stock Soared 64% Last Week - Investopedia